ASBP (Aspire Biopharma Holdings, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Aspire Biopharma Holdings, Inc. Common Stock (ASBP) is a publicly traded Healthcare sector company. As of May 21, 2026, ASBP trades at $5.97 with a market cap of $8.09M and a P/E ratio of 0.00. ASBP moved +2.06% today. Year to date, ASBP is -95.82%; over the trailing twelve months it is -97.91%. Its 52-week range spans $3.31 to $11,832.00. Rallies surfaces ASBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ASBP stock?

Rallies tracks hedge fund and 13F ownership for ASBP, including fund holders, share counts, and position changes when data is available.

ASBP Key Metrics

Key financial metrics for ASBP
MetricValue
Price$5.97
Market Cap$8.09M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.16%
52-Week High$11,832.00
52-Week Low$3.31
Volume3.27K
Avg Volume0
Revenue (TTM)$6.20K
Net Income$-24.48M
Gross Margin0.00%

Latest ASBP News

Recent ASBP Insider Trades

  • Fell Donald G. bought 10.50K (~$4.09K) on Jun 5, 2025.
  • Fell Donald G. sold 10.50K (~$4.09K) on Jun 5, 2025.
  • Fell Donald G. bought 9.50K (~$3.71K) on Jun 4, 2025.

ASBP Analyst Consensus

ASBP analyst coverage data. Average price target: $0.00.

Common questions about ASBP

Who owns ASBP stock?
Rallies tracks hedge fund and 13F ownership for ASBP, including fund holders, share counts, and position changes when data is available.
Does Rallies show 13F holders for ASBP?
Yes. Rallies tracks hedge fund and 13F ownership data for ASBP, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ASBP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ASBP. It does not provide personalized investment advice.
ASBP

ASBP